Subclones of bone marrow CD34 + cells in acute myeloid leukemia at diagnosis confer responses of patients to induction chemotherapy.
Ruinan JiaMin JiGuosheng LiYuan XiaShouhui GuoPeng LiYanping SunFei LuJingru ZhangShaolei ZangShuxin YanJingjing YeXiaokang JiDaoxin MaTao SunChun-Yan JiPublished in: Cancer (2022)
cells confers for outcomes of AML and provides biomarkers to predict the response of patients with AML to induction chemotherapy.
Keyphrases
- induced apoptosis
- bone marrow
- cell cycle arrest
- acute myeloid leukemia
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- endoplasmic reticulum stress
- peritoneal dialysis
- locally advanced
- squamous cell carcinoma
- oxidative stress
- allogeneic hematopoietic stem cell transplantation
- acute lymphoblastic leukemia
- radiation therapy
- weight loss
- pi k akt
- patient reported